GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $289,000 | -8.3% | 7,125 | -2.7% | 0.18% | -12.8% |
| Q2 2017 | $315,000 | -7.9% | 7,325 | -9.6% | 0.20% | -3.3% |
| Q1 2017 | $342,000 | -6.6% | 8,105 | -14.7% | 0.21% | -13.2% |
| Q4 2016 | $366,000 | -7.8% | 9,505 | +3.3% | 0.24% | -24.8% |
| Q3 2016 | $397,000 | +2.6% | 9,200 | +3.1% | 0.32% | +0.3% |
| Q2 2016 | $387,000 | +6.9% | 8,920 | 0.0% | 0.32% | +4.2% |
| Q1 2016 | $362,000 | -11.5% | 8,920 | -11.9% | 0.31% | -2.2% |
| Q4 2015 | $409,000 | +3.5% | 10,125 | -1.5% | 0.32% | +2.6% |
| Q3 2015 | $395,000 | -11.6% | 10,275 | -4.2% | 0.31% | -4.7% |
| Q2 2015 | $447,000 | +10.1% | 10,725 | +21.9% | 0.32% | +9.9% |
| Q1 2015 | $406,000 | +8.0% | 8,800 | 0.0% | 0.29% | +3.5% |
| Q4 2014 | $376,000 | -0.3% | 8,800 | +7.3% | 0.28% | -5.4% |
| Q3 2014 | $377,000 | -11.7% | 8,205 | +2.7% | 0.30% | -12.6% |
| Q2 2014 | $427,000 | 0.0% | 7,990 | 0.0% | 0.34% | -9.0% |
| Q1 2014 | $427,000 | -0.9% | 7,990 | -0.9% | 0.38% | -2.1% |
| Q4 2013 | $431,000 | – | 8,065 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |